{"related:WhO8ff2ajQUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5":[{"title":"Policies to enhance the efficiency of prescribing in the Spanish Catalan Region: impact and future direction","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.09.58","authors":["A Coma","A Coma C Zara","A Coma C Zara B Godman","A Coma C Zara B Godman A Agustí…"],"year":2009,"numCitations":59,"pdf":"http://www.academia.edu/download/44723908/Policies_to_enhance_the_efficiency_of_pr20160414-7049-13tvty8.pdf","citationUrl":"http://scholar.google.com/scholar?cites=400146355432723290&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:WhO8ff2ajQUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=400146355432723290&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis","p":1,"exp":1596890267920},{"title":"Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs","url":"https://link.springer.com/article/10.2165/00019053-200927050-00010","authors":["B Godman","B Godman U Schwabe","B Godman U Schwabe G Selke","B Godman U Schwabe G Selke B Wettermark"],"year":2009,"numCitations":54,"citationUrl":"http://scholar.google.com/scholar?cites=14942901218592284609&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:wd_xx3zZX88J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14942901218592284609&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Prescribing restrictions–a necessary strategy among some European countries to enhance future prescribing efficiency?","url":"http://test-journals-3.1.2.seedmedicalpublishers.com/index.php/rhc/article/view/55","authors":["B Godman","B Godman R Malmström…"],"year":2012,"numCitations":47,"pdf":"http://test-journals-3.1.2.seedmedicalpublishers.com/index.php/rhc/article/download/55/143","citationUrl":"http://scholar.google.com/scholar?cites=14567239018681576691&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:86y5-rQ6KcoJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14567239018681576691&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"test-journals-3.1.2 …"},{"title":"Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.09.73","authors":["D McGinn","D McGinn B Godman","D McGinn B Godman J Lonsdale","D McGinn B Godman J Lonsdale R Way…"],"year":2010,"numCitations":79,"citationUrl":"http://scholar.google.com/scholar?cites=11158286868588740589&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:7T8jsMky2poJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11158286868588740589&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.09.43","authors":["B Godman","B Godman T Burkhardt","B Godman T Burkhardt A Bucsics…"],"year":2009,"numCitations":60,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26883391_Impact_of_recent_reforms_in_Austria_on_utilization_and_expenditure_of_PPIs_and_lipid-lowering_drugs_Implications_for_the_future/links/551064d70cf2a8dd79bc8be5/Impact-of-recent-reforms-in-Austria-on-utilization-and-expenditure-of-PPIs-and-lipid-lowering-drugs-Implications-for-the-future.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13845080932298635994&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:2rox6MCbI8AJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13845080932298635994&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Insight into recent reforms and initiatives in Austria: implications for key stakeholders","url":"https://www.tandfonline.com/doi/abs/10.1586/14737167.8.4.357","authors":["B Godman","B Godman A Bucsics","B Godman A Bucsics T Burkhardt…"],"year":2008,"numCitations":78,"citationUrl":"http://scholar.google.com/scholar?cites=10748804950902017026&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:Aox5OidtK5UJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10748804950902017026&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Coping with changes in the defined daily dose in a longitudinal drug consumption database","url":"https://link.springer.com/content/pdf/10.1007/s11096-010-9366-0.pdf","authors":["V Vlahović"],"year":2010,"numCitations":43,"pdf":"https://www.researchgate.net/profile/Vera_Vlahovic-Palcevski/publication/41166897_Coping_with_changes_in_Defined_Daily_Dose_in_longitudinal_drug_consumption_databases/links/544105890cf2a6a049a412e3.pdf","citationUrl":"http://scholar.google.com/scholar?cites=9396960769715880895&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:v0MyZwi2aIIJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9396960769715880895&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Potential savings without compromising the quality of care","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2009.02129.x","authors":["C Norman","C Norman R Zarrinkoub","C Norman R Zarrinkoub J Hasselström…"],"year":2009,"numCitations":57,"pdf":"http://www.csb.cat/wp-content/uploads/2016/10/Reading-Correlations-paper-Norman-et-al-2009.pdf","citationUrl":"http://scholar.google.com/scholar?cites=844932739458079911&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:pxx_ktnNuQsJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=844932739458079911&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library"},{"title":"Soft regulations in pharmaceutical policy making","url":"https://link.springer.com/article/10.1007/BF03256147","authors":["B Wettermark","B Wettermark B Godman","B Wettermark B Godman B Jacobsson…"],"year":2009,"numCitations":99,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26865818_Soft_Regulations_in_Pharmaceutical_Policy_Making_An_Overview_of_Current_Approaches_and_their_Consequences/links/02e7e520d2e2e58ad9000000/Soft-Regulations-in-Pharmaceutical-Policy-Making-An-Overview-of-Current-Approaches-and-their-Consequences.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18293974578737482045&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:PYmsJ_RA4f0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18293974578737482045&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"European countries with small populations can obtain low prices for drugs: Lithuania as a case history","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.11.24","authors":["K Garuoliene","K Garuoliene B Godman","K Garuoliene B Godman J Gulbinovič…"],"year":2011,"numCitations":86,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/51217760_European_countries_with_small_populations_can_obtain_low_prices_for_drugs_Lithuania_as_a_case_history/links/5676c6f008ae0ad265c59fe4.pdf","citationUrl":"http://scholar.google.com/scholar?cites=6344570488949834669&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:rQNIpj5xDFgJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6344570488949834669&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"}]}